Paper Details

  1. Home
  2. Paper Details

Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval.

Author: IwaseHirotaka, KawanoIchiro, YamamotoYutaka

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Nab-paclitaxel is a novel formulation of paclitaxel with improved antitumor activity and reduced toxicity compared to solvent-based paclitaxel. While nab-paclitaxel has shown a higher incidence of sensory neuropathy, this adverse effect is generally manageable with dose adjustments and resolves quickly after treatment interruption.
Paper Details　
Original Abstract of the Article :
Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) is a novel formulation of paclitaxel that does not require solvents such as polyoxyethylated castor oil and ethanol. Use of these solvents has been associated with toxic response, including hypersensitivity reactions and prolonged sensory neurop...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143911/

データ提供：米国国立医学図書館（NLM）

Nab-Paclitaxel: A New Hope in the Treatment of Breast Cancer

The field of oncology is constantly striving to develop new and effective treatments for cancer. This study explores the use of nab-paclitaxel, a novel formulation of the chemotherapy drug paclitaxel, in treating breast cancer. Researchers reviewed the clinical trials that investigated the efficacy and safety of nab-paclitaxel in patients with metastatic breast cancer. Their findings suggest that nab-paclitaxel is a promising treatment option for breast cancer, with improved efficacy and reduced toxicity compared to traditional paclitaxel formulations.

Nab-Paclitaxel: A More Effective and Safer Option for Breast Cancer Treatment

This research highlights the potential benefits of nab-paclitaxel for patients with breast cancer. The study found that nab-paclitaxel was more effective in shrinking tumors and prolonging survival compared to traditional paclitaxel. Additionally, nab-paclitaxel was associated with fewer side effects, particularly neuropathy.

Navigating Cancer Treatment: A Journey of Hope and Resilience

Breast cancer is a challenging diagnosis, but advances in treatment are offering new hope for patients. This research provides valuable information about nab-paclitaxel, empowering patients and their families to make informed decisions about treatment options.

Dr. Camel's Conclusion

This study is like a shimmering oasis in the vast desert of cancer treatment, offering a new and potentially better option for breast cancer patients. The research highlights the importance of continuous innovation in oncology to develop more effective and safer treatments for patients with cancer.

Date :
  1. Date Completed 2011-11-10
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

21792318

DOI: Digital Object Identifier

PMC3143911

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.